-
-
-
-
-
-
-
Jefferies Assumes Protagonist Therapeutics (PTGX) at Buy, Sees 59% Upside
-
-
-
-
-
-
-
Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
-
-
-
-
-
-
UPDATE: Jefferies Starts Protagonist Therapeutics (PTGX) at Buy
-
-
-
-
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

